BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 21375212)

  • 21. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
    Chow L; Brown NE; Kunimoto D
    Clin Infect Dis; 2002 Nov; 35(9):e106-10. PubMed ID: 12384856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole].
    Kuga A; Oishi K; Ishida H; Kanda F
    Rinsho Shinkeigaku; 2007 May; 47(5):207-10. PubMed ID: 17585601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
    van 't Hek LG; Verweij PE; Weemaes CM; van Dalen R; Yntema JB; Meis JF
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1694-6. PubMed ID: 9603157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voriconazole versus amphotericin B for invasive aspergillosis.
    Karthaus M
    N Engl J Med; 2002 Dec; 347(25):2080-1; author reply 2080-1. PubMed ID: 12494937
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
    Ruchlemer R; Yinnon AM; Hershko C
    Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
    Wenzel R; Del Favero A; Kibbler C; Rogers T; Rotstein C; Mauskopf J; Morris S; Schlamm H; Troke P; Marciniak A
    J Antimicrob Chemother; 2005 Mar; 55(3):352-61. PubMed ID: 15728146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
    Wingard JR; Herbrecht R; Mauskopf J; Schlamm HT; Marciniak A; Roberts CS
    Transpl Infect Dis; 2007 Sep; 9(3):182-8. PubMed ID: 17605747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
    Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
    J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
    Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute isolated appendicitis due to Aspergillus carneus in a neutropenic child with acute myeloid leukemia.
    Decembrino N; Zecca M; Tortorano AM; Mangione F; Lallitto F; Introzzi F; Bergami E; Marone P; Tamarozzi F; Cavanna C
    New Microbiol; 2016 Jan; 39(1):65-9. PubMed ID: 26922988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
    Pagano L; Caira M; Candoni A; Offidani M; Martino B; Specchia G; Pastore D; Stanzani M; Cattaneo C; Fanci R; Caramatti C; Rossini F; Luppi M; Potenza L; Ferrara F; Mitra ME; Fadda RM; Invernizzi R; Aloisi T; Picardi M; Bonini A; Vacca A; Chierichini A; Melillo L; de Waure C; Fianchi L; Riva M; Leone G; Aversa F; Nosari A
    Haematologica; 2010 Apr; 95(4):644-50. PubMed ID: 19850903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decisions about voriconazole versus liposomal amphotericin B.
    Walsh TJ; Lee J; Dismukes WE
    N Engl J Med; 2002 May; 346(19):1499; author reply 1499. PubMed ID: 12000825
    [No Abstract]   [Full Text] [Related]  

  • 36. Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia.
    Imola M; Mianulli AM; Pasini G; Santelmo C; Drudi F; Fantini M; Corso V; Veneroni L; Ravaioli A
    G Chir; 2012 Mar; 33(3):74-6. PubMed ID: 22525550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of acute leukemia complicated by invasive aspergillosis in children].
    Liu Y; Tang SQ; Wang JW; Long H; Feng C; Zhang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):901-4. PubMed ID: 20113657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
    Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
    Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
    Klein KC; Blackwood RA
    Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.